Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation

Annals of Surgical Oncology

Volumn 15, Issue 11, 2008, Pages 3169-3177

  Heckman, Jason T ^a   Devera, Michael B ^a   Marsh, J Wallis ^a   Fontes, Paulo ^a   Amesur, Nikhil B ^a   Holloway, Shane E ^b   Nalesnik, Michael ^a   Geller, David A ^a   Steel, Jennifer L ^a   Gamblin, T Clark ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Bridge therapy; Hepatocellular carcinoma; Liver transplantation; Locoregional therapy; TACE; Yttrium

Indexed keywords

CISPLATIN; GEMCITABINE; OXALIPLATIN; YTTRIUM 90;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SURVIVAL TIME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; YTTRIUM RADIOISOTOPES;

EID: 55149117758     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0071-3     Document Type: Article

References (41)

1. HB El-Serag JA Davila NJ Petersen 2003 The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update Ann Intern Med 139 817 23
2. V Mazzaferro E Regalia R Doci 1996 Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 693 9
3. FY Yao L Ferrell NM Bass 2001 Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 1394 403
4. Mazzaferro V, Chun YS, Poon RT, et al. Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol 2008
5. JM Llovet J Fuster J Bruix 1999 Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation Hepatology 30 1434 40
6. FY Yao NM Bass B Nikolai 2003 A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy Liver Transpl 9 684 92
7. http://www.unos.org/PoliciesandBylaws2/policies/pdfs/policy_8.pdf. Organ Distribution: Allocation of Livers. Accessed 1 March 2008
8. RN Pugh IM Murray-Lyon JL Dawson 1973 Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 646 9
9. R Wiesner E Edwards R Freeman 2003 Model for end-stage liver disease (MELD) and allocation of donor livers Gastroenterology 124 91 6
10. MM Oken RH Creech DC Tormey 1982 Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 649 55
11. OM Ebied MP Federle BI Carr 2003 Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma Cancer 97 1042 50
12. BI Carr 2004 Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients Liver Transpl 10 S107 10
13. CM Lo H Ngan WK Tso 2002 Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164 71
14. JM Llovet MI Real X Montana 2002 Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 1734 9
15. C Camma F Schepis A Orlando 2002 Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 47 54
16. JM Llovet J Bruix 2003 Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival Hepatology 37 429 42
17. M Lesurtel B Mullhaupt BC Pestalozzi 2006 Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis Am J Transplant 6 2644 50
18. T Decaens F Roudot-Thoraval S Bresson-Hadni 2005 Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma Liver Transpl 11 767 75
19. A Veltri M Grosso MC Martina 1998 Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation: a retrospective study Cardiovasc Intervent Radiol 21 393 8
20. PM Porrett H Peterman M Rosen 2006 Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era Liver Transpl 12 665 73
21. PE Majno R Adam H Bismuth 1997 Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis Ann Surg 226 688 701
22. A Bharat DB Brown JS Crippin 2006 Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival J Am Coll Surg 203 411 20
23. IW Graziadei H Sandmueller P Waldenberger 2003 Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome Liver Transpl 9 557 63
24. YK Maddala L Stadheim JC Andrews 2004 Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization Liver Transpl 10 449 55
25. A Obed A Beham K Pullmann 2007 Patients without hepatocellular carcinoma progression after transarterial chemoembolization benefit from liver transplantation World J Gastroenterol 13 761 7
26. G Otto M Heise C Moench 2007 Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma Transplant Proc 39 537 9
27. H Bismuth L Chiche R Adam 1993 Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients Ann Surg 218 145 51
28. Y Fong RL Sun W Jarnagin 1999 An analysis of 412 cases of hepatocellular carcinoma at a Western center Ann Surg 229 790 9 discussion 799-800
29. J Figueras E Jaurrieta C Valls 2000 Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy J Am Coll Surg 190 580 7
30. RT Poon ST Fan CM Lo 2002 Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation Ann Surg 235 373 82
31. RT Poon ST Fan 2004 Resection prior to liver transplantation for hepatocellular carcinoma: a strategy of optimizing the role of resection and transplantation in cirrhotic patients with preserved liver function Liver Transpl 10 813 5
32. J Belghiti A Cortes EK Abdalla 2003 Resection prior to liver transplantation for hepatocellular carcinoma Ann Surg 238 885 92
33. FY Yao NM Bass B Nikolai 2002 Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list Liver Transpl 8 873 83
34. D Cherqui A Laurent C Tayar 2006 Laparoscopic liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: midterm results and perspectives Ann Surg 243 499 506
35. SN Hong SY Lee MS Choi 2005 Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function J Clin Gastroenterol 39 247 52
36. DS Lu NC Yu SS Raman 2005 Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation Hepatology 41 1130 7
37. V Mazzaferro C Battiston S Perrone 2004 Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study Ann Surg 240 900 9
38. M Pompili VG Mirante G Rondinara 2005 Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence Liver Transpl 11 1117 26
39. Belghiti J. CB, Greig PD, Lencioni R, et al. Treatment before Liver Transplantation for HCC. Ann Surg Oncol 2008; Jan 31(Epub ahead of print)
40. R Salem RJ Lewandowski B Atassi 2005 Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival J Vasc Interv Radiol 16 1627 39
41. LM Kulik B Atassi L van Holsbeeck 2006 Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation J Surg Oncol 94 572 86